Hyaluronan

PreclinicalSmall molecule

HHadassah Medical Organization

Hyaluronan is one of 2 small molecule programs targeting Hyaluronic Acid. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Hyaluronic AcidCompleted

Hyaluronic AcidPreclinical

Completed

Competition

Competitive Landscape

3 competitors in Hyaluronic Acid

#DrugCompanyPhaseTrials

Activella

Eli Lilly

Preclinical

1 2

Hyaluronan

HHadassah Medical Organization

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Osteoarthritis3 trials

Efficacy and Safety Study in Patients Suffering From Knee Osteoarthritis

Withdrawn·PPierre Fabre Medicament·N/A·NCT01469507

Daily Activity and Gait Analysis After Viscosupplement Injection Among Hip Osteoarthritis Patients

Completed·LLaval University·Phase 4·NCT02086474·38 enrolled

Effect of Different Injection Regimens of Autologous Conditioned Plasma for Knee Osteoarthritis

Completed·AAndrews Research & Education Foundation·Phase 2/3·NCT03889925·64 enrolled

Anterior Cruciate Ligament Reconstruction1 trial

Safety and Efficacy Study of MSB-CAR001 in Subjects 6 Weeks Post an Anterior Cruciate Ligament Reconstruction

Completed·MMesoblast, Ltd.·Phase 1/2·NCT01088191·17 enrolled

Hyaluronic Acid1 trial

Minimally Invasive Volume Augmentation of Papillae Around Implant Restorations With Hyaluronic Acid Injection

Completed·MMalmö University·N/A·NCT02536807·22 enrolled

Liver1 trial

A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy

Completed·MMesoblast International Sàrl·Phase 1/2·NCT00225095·60 enrolled

Intrauterine Adhesions1 trial

Safety Study of Use of Hyaluronic Acid Gel To Prevent Intrauterine Adhesions In Hysteroscopic Surgery

Unknown status·HHadassah Medical Organization·Phase 1·NCT01464528·10 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Hyaluronan. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Hyaluronan compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Hyaluronan. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hadassah Medical Organization company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: HHadassah Medical Organization

Hyaluronan

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Osteoarthritis3 trials

Anterior Cruciate Ligament Reconstruction1 trial

Hyaluronic Acid1 trial

Liver1 trial

Intrauterine Adhesions1 trial

References

Drug Info

Quick Facts

Related News